Pharmabiz

Philips & Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology

Philips & Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology: Amsterdam, the Netherland ...
Pharmabiz

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines Vaxxitek HVT+IBD+H5 and Vaxxinact H5

Ingelheim, Germany Friday, November 21, 2025, 16:00 Hrs [IST] ...
Pharmabiz

Solventum to acquire privately held bioscience company, Acera Surgical for up to $850 million

Solventum to acquire privately held bioscience company, Acera Surgical for up to $850 million: St. Paul, Minnesota Friday, November 21, 2025, 15:00 Hrs [IST] Solventum, a healthca ...
Pharmabiz

AIOCD asks traders to strictly comply with the ban on 35 FDCs

AIOCD asks traders to strictly comply with the ban on 35 FDCs: Peethaambaran Kunnathoor, Chennai Friday, November 21, 2025, ...
Pharmabiz

NCISM grants permission to 31 new Ayurveda Medical Colleges in AY 2025-26

NCISM grants permission to 31 new Ayurveda Medical Colleges in AY 2025-26: Gireesh Babu, New Delhi Friday, November 21, 2025, ...
Pharmabiz

Moderna expands US manufacturing with onshoring of drug product capabilities

Moderna expands US manufacturing with onshoring of drug product capabilities: Cambridge, Massachusetts Friday, November 21, 2025, 13:00 Hrs [IST] Moderna, Inc. announced the expan ...
Pharmabiz

HitGen receives new funding to discover novel therapeutics for underserved diseases

HitGen receives new funding to discover novel therapeutics for underserved diseases: Chengdu, China Friday, November 21, 2025, 14:00 Hrs [IST] HitGen Inc. (HitGen), a drug discove ...
Pharmabiz

Ramaiah Memorial Hospital & Ramaiah Medical College host Global WBMT Symposium on Cell Therapy

Ramaiah Memorial Hospital & Ramaiah Medical College host Global WBMT Symposium on Cell Therapy: Our Bureau, Bengaluru Friday, November 21, 2025, 13:30 Hrs [IST] Ramaiah Memorial H ...
Pharmabiz

Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC

Bayer’s Hyrnuo gets US FDA accelerated approval to treat patients with previously treated advanced HER2-mutant NSCLC: Berlin Friday, November 21, 2025, 11:00 Hrs [IST] Following ...
Pharmabiz

Chugai obtains approval for FoundationOne CDx Cancer Genomic Profile to be used as a companion diagnostic for repotrectinib with NTRK fusion-positive solid-tumours

Chugai obtains approval for FoundationOne CDx Cancer Genomic Profile to be used as a companion diagnostic for repotrectinib with NTRK fusion-positive solid-tumours: Tokyo Friday, ...
Pharmabiz

Brenntag Specialties signs global distribution agreement with Calyxia for advanced materials solutions

Brenntag Specialties, a global leader for innovative specialty and ingredients distribution in life science and material science, announced a partnership with Calyxia to distribute their microcapsules ...
Pharmabiz

Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1

Alexion’s Koselugo approved in US for adults with neurofibromatosis type 1: Cambridge, UK Friday, November 21, 2025, 09:00 Hrs [IST] Alexion, AstraZeneca Rare Disease’s Koselu ...